Inventor · disambiguated record
Daniel Elbaum
Also filed as: ELBAUM DANIEL
40 granted patents·16 pending applications·657 citations·filing 2000–2023
98Inventor score
Files withAMGEN INC16RA PHARMACEUTICALS INC16CORNERSTONE THERAPEUTICS INC4CYSTIC FIBROSIS FOUND4QURALIS CORP2
Top patents by PatentIndex Score
56 records- 0198US6653309B1Inhibitors of IMPDH enzyme technical field of the inventionVERTEX PHARMA·Filed 2000·Granted Nov 25, 2003·131 cites·19 claims
- 0297US10435438B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Oct 8, 2019·12 cites·21 claims
- 0397US10106579B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·19 cites·20 claims
- 0496US10208089B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·12 cites·21 claims
- 0595US10328115B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·15 cites·22 claims
- 0695US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 0794US11014965B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted May 25, 2021·3 cites·18 claims
- 0894US10588936B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·13 cites·20 claims
- 0994US9937222B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·14 cites·15 claims
- 1092US6995162B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Feb 7, 2006·48 cites·26 claims
- 1191US10918691B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·2 cites·21 claims
- 1291US7102009B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 5, 2006·49 cites·20 claims
- 1390US7514564B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2006·Granted Apr 7, 2009·16 cites·15 claims
- 1489US7989498B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Granted Aug 2, 2011·19 cites·1 claims
- 1589US7531553B2Heterocyclic compounds and methods of useAMGEN INC·Filed 2004·Granted May 12, 2009·44 cites·15 claims
- 1689US7074789B2Kinase inhibitorsAMGEN INC·Filed 2003·Granted Jul 11, 2006·25 cites·7 claims
- 1787US12239684B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·13 claims
- 1887US7105682B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 12, 2006·29 cites·17 claims
- 1987US6495558B1Kinase inhibitorsAMGEN INC·Filed 2000·Granted Dec 17, 2002·18 cites·5 claims
- 2086US8642624B2Substituted alkylamine derivatives and methods of useCHEN GUOQING·Filed 2011·Granted Feb 4, 2014·11 cites·3 claims
- 2186US7943622B2Piperazines, pharmaceutical compositions and methods of use thereofCORNERSTONE THERAPEUTICS INC·Filed 2007·Granted May 17, 2011·3 cites·2 claims
- 2285US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 2384US9238676B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·2 cites·20 claims
- 2484US6387890B1Compositions and methods for inhibiting arginase activityUNIV PENNSYLVANIA·Filed 2000·Granted May 14, 2002·18 cites·26 claims
- 2583US10301315B2Pyrrolopyrimidines as CFTR potentiatorsCYSTIC FIBROSIS FOUND THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·1 cites·20 claims
- 2682US11535650B1Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2022·Granted Dec 27, 2022·0 cites·2 claims
- 2782US10272132B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2018·Granted Apr 30, 2019·1 cites·20 claims
- 2881US10494374B2Pyrrolopyrimidines as CFTR potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Granted Dec 3, 2019·1 cites·67 claims
- 2981US8008499B2Anabaseine derivatives, pharmaceutical compositions and methods of use thereofCORNERSTONE THERAPEUTICS INC·Filed 2009·Granted Aug 30, 2011·4 cites·1 claims
- 3080US7320992B2Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of useAMGEN INC·Filed 2004·Granted Jan 22, 2008·15 cites·38 claims
- 3180US6723710B2Compositions for inhibiting arginase activityUNIV PENNSYLVANIA·Filed 2002·Granted Apr 20, 2004·12 cites·2 claims
- 3278US11965040B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Apr 23, 2024·0 cites·12 claims
- 3377US7442698B2Substituted heterocyclic compounds and methods of useAMGEN INC·Filed 2004·Granted Oct 28, 2008·11 cites·12 claims
- 3477US2023250100A1Pyrrolopyrimidines as CFTR PotentiatorsCYSTIC FIBROSIS FOUND·Filed 2023·Application pending·0 cites
- 3575US11707503B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·0 cites·20 claims
- 3675US9644004B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·1 cites·20 claims
- 3775US9428522B2Piperazines, pharmaceutical compositions and methods of use thereofCORNERSTONE THERAPEUTICS INC·Filed 2014·Granted Aug 30, 2016·1 cites·5 claims
- 3872US7662965B2Anabaseine derivatives, pharmaceutical compositions and method of use thereofCORNERSTONE THERAPEUTICS INC·Filed 2007·Granted Feb 16, 2010·1 cites·10 claims
- 3972US2020017512A1Pyrrolopyrimidines as cftr potentiatorsCYSTIC FIBROSIS FOUND·Filed 2019·Application pending·0 cites
- 4069US2021171534A1Pyrrolopyrimidines as CFTR PotentiatorsCYSTIC FIBROSIS FOUND·Filed 2021·Application pending·0 cites
- 4168US8822472B2Piperazines, pharmaceutical compositions and methods of use thereofCLARK ROGER B·Filed 2011·Granted Sep 2, 2014·1 cites·2 claims
- 4266US2025051766A1Treatment of neurological diseases using modulators of unc13a gene transcriptsHINCKLEY SANDRA·Filed 2022·Application pending·0 cites
- 4364US9999650B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2017·Granted Jun 19, 2018·0 cites·25 claims
- 4460US2023235332A1Treatment of neurological diseases using modulators of gene transcriptsQURALIS CORP·Filed 2021·Application pending·0 cites
- 4559US2017136007A1Novel piperazines, pharmaceutical compositions and methods of use thereofTHE FEINSTEIN INST MEDICAL RES·Filed 2016·Application pending·0 cites
- 4658US2013273004A1Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 4757US2005153960A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 4856US2022372489A1Ppm1a inhibitors and methods of using sameQURALIS CORP·Filed 2020·Application pending·0 cites
- 4951US2003134836A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2002·Application pending·0 cites
- 5049US2004063666A1Compositions for inhibiting arginase activityFiled 2003·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel Elbaum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →